Authors

  • Julian Savulescu
    Uehiro Chair in Practical Ethics Director, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Mark Sheehan
    James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
  • Peter Taylor
    Research Associate, Future of Humanity Institute, University of Oxford
  • Anders Sandberg
    James Martin Research Fellow, Future of Humanity Institute, University of Oxford
  • Guy Kahane
    Deputy Director, Oxford Uehrio Centre for Practical Ethics, University of Oxford
  • Toby Ord
    Research Associate, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Dominic Wilkinson
    DPhil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Rebecca Roache
    James Martin Research Fellow, Future of Humanity Institute, University of Oxford
  • S. Matthew Liao
    Deputy Director, and James Martin Senior Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
  • Steve Clarke
    James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
  • Neil Levy
    James Martin Research Fellow, Program on the Ethics of the New Biosciences, University of Oxford
  • Tom Douglas
    DPhil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Rafaela Hillerbrand
    James Martin Research Fellow, Future of Humanity Institute, University of Oxford
  • Luciano Floridi
    Research Chair in Philosophy of Information, Department of Philosophy, University of Hertfordshire and Fellow of St Cross College, University of Oxford
  • Janet Radcliffe Richards
    Distinguished Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Nick Bostrom
    Director, Oxford Future of Humanity Institute, University of Oxford
  • Lachlan de Crespigny
    Principal Fellow, Department of Obstetrics and Gynaecology, University of Melbourne; Honorary Fellow, Murdoch Children's Research Institute; Research Associate, Oxford Uehiro Centre for Practical Ethics
  • Roger Crisp
    Uehiro Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Barbro Fröding nee Bjorkman
    Marie Curie Postdoctoral Research Fellow, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Francesca Minerva
    Visiting Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • David Edmonds
    Research Associate, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Pablo Stafforini
    DPhil Student, Oxford Centre for Neuroethics, University of Oxford
  • Alexandre Erler
    Dphil Student, Oxford Uehiro Centre for Practical Ethics, University of Oxford
  • Russell Powell
    Research Fellow, Science and Religious Conflict, Oxford Uehiro Centre for Practical Ethics, University of Oxford

Cited By

  • Intute Logo

Recommend this site

News Feeds

Blog powered by TypePad

Research Ethics

July 11, 2009

Hunger for long life: the ethics of caloric restriction experiments

This has been a good week for life extension research, with the Nature paper Rapamycin fed late in life extends lifespan in genetically heterogeneous mice by Harrison et al. (free News and Views) showing that the drug boosts lifespan in middle aged mice, and Science countering with Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys by Colman et al. showing that in a 20-year longitudinal study rhesus monkeys do seem to benefit from caloric restriction (CR). CR involves keeping the energy intake low, but not so low that it induces starvation.

Not everybody seems to like the experiment. The Swedish major newspaper Dagens Nyheter had an article by Per Snaprud that appeared to criticise the monkey experiment on ethical grounds. He quotes Mats Spångberg, chief veterinarian at the Swedish Institute for Infectious Disease Control, who doubts the experiment would have been approved in Sweden. The only use of monkeys in Swedish research is AIDS vaccine research. The article concludes by stating that the virus kills 2 million people every year, 270,000 of whose are children.

But ageing kills 100,000 people worldwide each day directly or indirectly. 100% of humans and monkeys are "infected".

Continue reading "Hunger for long life: the ethics of caloric restriction experiments" »

July 09, 2009

Informed consent in the Googlesphere

Here's an interesting snippet

But there's also the fact that Google is stuffed full of people who just love to experiment on its users. For instance, Google Mail uses a very slightly different blue for links than the main search page. Its engineers wondered: would that change the ratio of clickthroughs? Is there an "ideal" blue that encourages clicks? To find out, incoming users were randomly assigned between 40 different shades of links – from blue-with-green-ish to blue-with-blue-ish. It turned out blue-ness encouraged clicks more than green-ness. Who would have guessed? And who would have cared? Google, of course, which wants to get people clicking around the net.


I take this sort of experimentation as utterly, boringly unproblematic

But on one view - this is surreptitious experimentation without consent including randomisation.

Continue reading "Informed consent in the Googlesphere" »

June 15, 2009

Not better than the alternative: an informal experimentation tragedy

Police are reinvestigating the 2007 death of Yolanda Cox, a woman who collapsed in anaphylactic shock after being injected with an experimental drug by her sister, a GP. The drug was developed by their mother, originally intended to treat diabetes but apparently believed to extend lifespan. After testing on diabetic patients and apparently themselves without any apparent side effects the mother and sister gave it to the woman three times, with tragic consequences the third time. Was it a failure of medical ethics, research ethics - or plain psychological bias?

Continue reading "Not better than the alternative: an informal experimentation tragedy" »

May 28, 2009

Shining monkey, sadistic conclusion?

Japanese researchers have genetically modified marmoset monkeys, and demonstrated that the modification can be inherited by their offspring. The modification was the standard green fluorescent protein making the monkey's glow green under UV light, a marker to demonstrate that the modification worked (BBC shows a picture of their feet glowing "an eerie green", while the picture in Nature's News and Views shows the cute monkeys in normal light and the original paper shows both). The long-term aim is to be able to produce transgenic primates that could act as disease models for humans - many conditions do not map well onto mice and rats. But is it acceptable to introduce heritable illness conditions into animals?

Continue reading "Shining monkey, sadistic conclusion?" »

January 23, 2009

Stem Cell Trials – Should They Go Ahead? Why Harm to Patients Is Not a Reason to Stop Them

Professor Savulescu comments:

Professor Julian Savulescu is Uehiro Chair in Practical Ethics and Director of the Uehiro Centre for Practical Ethics at Oxford, Director of the Oxford Centre for Neuroethics, and Director of the Program on the Ethics of the New Biosciences. He was also recently awarded a major Arts and Humanities Research Council grant on Cognitive Science and Religious Conflict.


THE FDA has approved for the first time a clinical trial of embryonic stem cells to treat spinal injury patients. The trial will be conducted by Geron. A similar trial by Reneuron has been approved recently in the UK (The Scotsman, and the BBC). The research in the UK to treat stroke patients has already attracted stern criticism from “ethical campaigners.” The first wave predictably objected on the ground that it involved abortion "It involves cannibalising an unborn child.” But no child was aborted for the purposes of providing stem cells. These would have involved abortions that would anyway have occurred for a variety of reasons. Such opponents predictably object to anything involving destruction of embryos and fetuses – abortion, IVF, prenatal testing, contraception – so it is hardly surprising that they would object to this form of medical treatment.

The second wave of ethical campaigners, not clearly distinct from the first, claim now that the treatment is too risky. But is it too risky?

Continue reading "Stem Cell Trials – Should They Go Ahead? Why Harm to Patients Is Not a Reason to Stop Them" »

December 11, 2008

I just don’t care about animals that much!

Despite the protestations of those opposed to the use of animals in research, the fundamental differences between people over the treatment of animals seems to lie with the weight that we are prepared to give to animal suffering and death in the pursuit of human goods and interests. Very few, I would have thought, would give animal suffering no weight and similarly, very few would give animal suffering more weight than human suffering.

Continue reading "I just don’t care about animals that much!" »

November 17, 2008

Animal experimentation: morally acceptable, or just the way things always have been?

Following the announcement last week that Oxford University’s controversial Biomedical Sciences building is now complete and will be open for business in mid-2009, the ethical issues surrounding the use of animals for scientific experimentation have been revisited in the media—see, for example, here , here, and here.

The number of animals used per year in scientific experiments worldwide has been estimated at 200 million—well in excess of the population of Brazil and over three times that of the United Kingdom. If we take the importance of an ethical issue to depend in part on how many subjects it affects, then, the ethics of animal experimentation at the very least warrants consideration alongside some of the most important issues in this country today, and arguably exceeds them in importance. So, what is being done to address this issue?

Continue reading "Animal experimentation: morally acceptable, or just the way things always have been?" »

November 10, 2008

Hacking the spammers

Why is there spam? The simple answer is that "there is a sucker born every minute" and email is cheap enough to reach millions of potential suckers who might want to buy Viagra, sure-fire investments and fake Rolexes. A new study has discovered that it is enough with one response to every 12.5 million emails sent is enough to be profitable. The most interesting about the study was how it was done: by hacking the spammers own network. But is it OK to hack in order to understand spam?

Continue reading "Hacking the spammers" »

September 30, 2008

The price of ignorance: the Durham study and research ethics

Ben Goldacre (who seems to be one of this blog's favorite sources) tears into the Durham fish oil trial. A while ago Durham County together with the company Equazen decided to test whether giving omega-3 supplements would improve the GCSE scores of children. Unfortunately there were clear problems with the trial design. In the face of criticism the organisations involved refused to give out information on the experimental setup and even claimed not to be running it as a trial (despite numerous statements to the press). GCSE scores did not generally increase. Despite this, now positive results are claimed - largely because what is measured has been changed to suit the data. The most vexing thing about the whole affair is that the trial could have been done in a proper manner for the same amount of money.

Continue reading "The price of ignorance: the Durham study and research ethics" »

September 24, 2008

Publishing Negative Research Results

Ben Goldacre, in the Guardian this weekend, noticed the range of headlines on health and health risks that are to be found in the media. He mentions, among others, the rise of ‘manorexia’, the failure of water to induce weight loss and the dangers of antibiotics to prevent premature birth. I found a couple more: It turns out that dark chocolate can reduce the risk of heart attacks, vegetable rich diets and in particular vegetables like broccoli reduce the chance of heart disease and stroke and turmeric, the spice that makes curries yellow, can reduce the size of hemorrhagic stroke.

It’s quite striking what research is done!

Continue reading "Publishing Negative Research Results" »

Search

  • Google Search

    WWW
    practicalethicsnews.com

July 2009

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Enter your email address:

Delivered by FeedBurner